• Send Us A Tip
  • Calling all Tech Writers
  • Advertise
Wednesday, May 14, 2025
  • Login
  • Register
TechStory
  • News
  • Crypto
  • Gadgets
  • Memes
  • Gaming
  • Cars
  • AI
  • Startups
  • Markets
  • How to
No Result
View All Result
  • News
  • Crypto
  • Gadgets
  • Memes
  • Gaming
  • Cars
  • AI
  • Startups
  • Markets
  • How to
No Result
View All Result
TechStory
No Result
View All Result
Home News

Cancer Couple Behind Covid 19 Shot Claims That Cancer Vaccine Will Be Available Before 2030

by Aditi Bali
October 17, 2022
in News, Popular, Trending, World
Reading Time: 2 mins read
0
Understanding The Basics Of Cancer Genetics

(Image Credits : theoncologyinstituteofhopeandinnovations.wordpress.com)

TwitterWhatsappLinkedin

According to recent reports, the scientist couple behind the covid 19 shot has claimed that the cancer vaccine will be available before 2030. Read the entire article to learn more about this vaccine.

You might also like

Adopt AI and Flam Raise $20M to Power the Future of AI and Mixed Reality

Trump’s Visit to Saudi Arabia: Focus on Iran, Investment, and Israel

Leadership Chaos Hits U.S. Copyright Office Amid AI Policy Battle

About the vaccine

“Yes, we feel that a cure for cancer, or to changing cancer patients’ lives, is in our grasp,” said Professor Ozlem Tureci during an interview on BBC’s “Sunday with Laura Kuenssberg.”  “We believe that this will happen, definitely, before 2030,” he told Keunssberg.

“The goal that we have is that can we use the individualized vaccine approach to ensure that directly after surgery, patients receive a personalized, individualized vaccine, and we induce an immune response that so the T-cells in the body of the patient can screen the body for remaining tumor cells and ideally eliminate the tumor cells,” Sahin explained.

Keunssberg asked the couple if there was “still a chance” that the cancer vaccine doesn’t work.” I don’t think so,” replied Tureci. “Everything we have learned about the immune system and about what we achieve with a cancer vaccine shows, in principle, the clear activity — we can induce those killer T-cells, we can direct them.” “Every step and every patient we treat in these cancer trials helps us to understand more about what we are against and how to address that,” said Tureci.

Professor Ozlem Tureci and Dr. Ugur Sahin, Source- Anadolu Agency

 

About BioNTech

The scientist couple, Professor Ozlem Tureci and Dr. Ugur Sahin cofounded BioNTech. It is the company that partnered which Pfizer to provide one of the most effective covid vaccines. To explain the working of the covid 19 vaccine, Sahin said

“We are a next-generation immunotherapy company,” Sahin told CNBC’s “Power Lunch” on Tuesday. “The technology behind this vaccine, the messenger RNA technology, and the vaccine candidates have been developed in Germany.”

Sahin went on to explain that BioNTech “took care of the manufacturing of the batches for the clinical trial.” BioNTech also specializes in T-cell, a key part of the immune system, and “investigated the T-cell immune responses for this vaccine,” according to its chief.

About Covid 19

Covid 19 is one of the most shocking pandemics that hit the world in the year 2019. It is an extremely infectious disease and it took quite a while to fade away. As of now, it is still prevalent in many parts of the world and has caused a lot of deaths. An extremely infectious disease, it originated in China in the state of Wuhan and rapidly spread all across the world.

Tags: cancer vaccineLatestNewsrecenttrending
Tweet54SendShare15
Previous Post

France approves its third-biggest bank to operate digital asset services

Next Post

Michael Burry Attacks Facebook, says its in Big Trouble

Aditi Bali

Recommended For You

Adopt AI and Flam Raise $20M to Power the Future of AI and Mixed Reality

by Ishaan Negi
May 14, 2025
0
Adopt AI and Flam Raise $20M to Power the Future of AI and Mixed Reality

In a powerful endorsement of India’s rising stature in the global deep-tech space, two emerging technology startups—Adopt AI and Flam—have collectively secured $20 million in funding.

Read more

Trump’s Visit to Saudi Arabia: Focus on Iran, Investment, and Israel

by Thomas Babychan
May 14, 2025
0
Trump’s Visit to Saudi Arabia: Focus on Iran, Investment, and Israel

President Donald Trump’s arrival in Saudi Arabia on May 13, 2025, marked the beginning of a carefully planned visit to the Middle East during his second term in...

Read more

Leadership Chaos Hits U.S. Copyright Office Amid AI Policy Battle

by Harikrishnan A
May 14, 2025
0
Trump-Appointed Officials Denied Entry to U.S. Copyright Office Amid Leadership Shake-Up

In a scene straight out of a political thriller, two men arrived at the U.S. Copyright Office in Washington, D.C. earlier this week claiming to be newly appointed...

Read more
Next Post
Meta Has To Pay Walkie Talkie App $174 Million for Infringing on its Patents

Michael Burry Attacks Facebook, says its in Big Trouble

Please login to join discussion

Techstory

Tech and Business News from around the world. Follow along for latest in the world of Tech, AI, Crypto, EVs, Business Personalities and more.
reach us at [email protected]

Advertise With Us

Reach out at - [email protected]

BROWSE BY TAG

#Crypto #howto 2024 acquisition AI amazon Apple bitcoin Business China cryptocurrency e-commerce electric vehicles Elon Musk Ethereum facebook flipkart funding Gaming Google India Instagram Investment ios iPhone IPO Market Markets Meta Microsoft News NFT samsung Social Media SpaceX startup startups tech technology Tesla TikTok trend trending twitter US

© 2024 Techstory.in

No Result
View All Result
  • News
  • Crypto
  • Gadgets
  • Memes
  • Gaming
  • Cars
  • AI
  • Startups
  • Markets
  • How to

© 2024 Techstory.in

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?